Managed Healthcare Executive6h
New Trial to Investigate Osteoporosis Drug for Type 1 Diabetes
The study explores whether Prolia/Xgeva (denosumab), a widely used therapy for osteoporosis and bone tumors, can regenerate ...
Center for Biosimilars6h
The Top 5 Biosimilar Articles for the Week of March 31
Number 5: Biosimilar natalizumab demonstrated comparable efficacy, safety, and immunogenicity to reference drug Tysabri in ...
Managed Healthcare Executive23h
FDA Grants Accelerated Approval to Vanrafia for IgAN, a Rare Kidney Disease
Vanrafia reduces proteinuria in adults with primary immunoglobulin A nephropathy (IgAN). It has a wholesale acquisition cost ...